Table 2.
Hepatitis B virus vaccination and no reply rates across study centers
| n | No reply n (%) |
Immunization coverage |
|||
| Vaccinated n3 | Per protocol1 (%) | ITT2 (%) | |||
| Total | 1215 | 313 (25.8) | 99 | 11 | 8.2 |
| General practitioner | 418 | 85 (20.3) | 21 | 6.3 | 5 |
| Policlinique Saint Antoine | 165 | 47 (28.5) | 10 | 8.6 | 6.1 |
| Travel clinic Saint Antoine | 31 | 5 (16.1) | 3 | 11.5 | 10 |
| CPAM | 222 | 33 (14.9) | 8 | 4.2 | 3.6 |
| STD clinics | 635 | 166 (26.1) | 35 | 7.5 | 5.5 |
| CDAG Saint Antoine | 51 | 10 (19.6) | 0 | 0 | 0 |
| CDAG Figuier | 275 | 78 (28.4) | 22 | 11.2 | 8 |
| CDAG Belleville | 309 | 78 (25.2) | 13 | 5.6 | 4.2 |
| Immigrant-health clinics | 140 | 61 (43.6) | 37 | 46.8 | 26.4 |
| Croix-Rouge Moulin Joly | 9 | 0 (0) | 5 | 55.6 | 55.6 |
| CRAMIF | 18 | 0 (0) | 9 | 50 | 50 |
| Médecin du Monde | 113 | 61 (54.0) | 23 | 44.2 | 20.4 |
| Prison (UCSA Paris) | 22 | 0 (0) | 6 | 27.3 | 27.3 |
1
Per-protocol end-point defined as the proportion of non-immunized participants initiating vaccination who were contacted;
2
Intent-to-treat (ITT) end-point defined as the proportion of non-immunized participants initiating vaccination assuming that those who were unable to be contacted did not initiate or complete vaccination;
3
Participants initiating HBV vaccination sequence after HBV testing in the OPTISCREEN-B study. CDAG: Centre de dépistage anonyme et gratuit; CPAM: Caisse primaire d’assurance maladie; CRAMIF: Caisse régionale d'assurance maladie d'Ile-de-France; UCSA: Unité de consultations et de soins ambulatoire; STD: transmitted disease.